Osteopontin Gene Polymorphisms Are Associated with Cardiovascular Risk Factors in Patients with Premature Coronary Artery Disease

Osteopontin (OPN) is considered a clinical predictor of cardiovascular disease. We aimed to evaluate the association of the OPN gene polymorphisms rs2728127 and rs11730582 with the development of premature coronary artery disease (pCAD), cardiovascular risk factors, and cardiometabolic parameters. We evaluated 1142 patients with pCAD and 1073 controls. Both polymorphisms were determined by Taqman assays. Similar allele and genotype frequencies were observed in both groups; additionally, an association of these polymorphisms with CAD and cardiometabolic parameters was observed in both groups. In patients with pCAD, the rs11730582 was associated with a high risk of hypoadiponectinemia (OR = 1.300, P (additive) = 0.003), low risk of hypertension (OR = 0.709, P (codominant 1) = 0.030), and low risk of having high non-HDL cholesterol (OR = 0.637, P (additive) = 0.038). In the control group, the rs2728127 was associated with a low risk of fatty liver (OR = 0.766, P (additive) = 0.038); while the rs11730582 was associated with a low risk of hypoadiponectinemia (OR = 0.728, P (dominant) = 0.022), and risk of having elevated apolipoprotein B (OR = 1.400, P (dominant) = 0.031). Our results suggest that in Mexican individuals, the rs11730582 and rs2728127 OPN gene polymorphisms are associated with some abnormal metabolic variables in patients with pCAD and controls.